Altria is in a strong uptrend, with the stock up 22.9% over the past year, outperforming the S&P 500's 19.1% gain. The current price of $72.71 sits at 97.5% of its 52-week range ($54.70–$74.56), indicating the stock is near its highs and reflecting robust momentum. This positioning suggests bullish sentiment but also raises caution about potential overextension, as the stock is trading just 2.5% below its 52-week high. Short-term momentum is accelerating, with a 1-month gain of 5.0% and a 3-month gain of 10.6%, both outpacing the S&P 500's respective returns of -1.25% and 13.56%. The 1-month relative strength of 6.26% versus the S&P 500 confirms near-term outperformance, and the 6-month change of 26.9% aligns with the longer-term uptrend, showing no divergence. The stock's beta of 0.49 indicates it is significantly less volatile than the market, making it a defensive holding. Key support lies at the 52-week low of $54.70, while resistance is at the 52-week high of $74.56. A breakout above $74.56 would signal continued upside momentum, while a breakdown below $54.70 would be a bearish reversal. The low beta suggests the stock is less sensitive to broad market swings, which is typical for a consumer staple.

Altria's revenue trajectory is mixed but showing recent acceleration. In Q4 2025, revenue grew 14.5% year-over-year to $5.846 billion, driven by smokeable products ($5.119 billion) and smokeless products ($706 million). However, revenue in Q3 2025 was $5.251 billion, and Q2 2025 was $5.290 billion, indicating sequential growth. The multi-quarter trend shows a recovery from Q1 2025's $4.519 billion, suggesting a rebound in demand or pricing power. The company's profitability is robust, with a net income of $1.117 billion in Q4 2025 and a net margin of 19.1%. Gross margin is high at 62.1% for Q4 2025, though down from 72.6% in Q3 2025, likely due to product mix shifts. Operating margin for Q4 2025 was 28.2%, reflecting strong pricing but some cost pressures. The company is consistently profitable, with trailing twelve-month net income of $6.947 billion. Altria's balance sheet shows a debt-to-equity ratio of -7.34, which is negative due to negative shareholders' equity (a common feature for tobacco companies with large debt and share buybacks). Free cash flow is strong at $9.074 billion TTM, and the company generated $3.271 billion in operating cash flow in Q4 2025 alone. The current ratio of 0.61 indicates tight liquidity, but the massive cash flow generation supports dividend payments and debt servicing. ROE is negative (-198.4%) due to negative equity, but ROA of 27.6% reflects efficient asset use.